Live feed08:00:00·397dPRReleasevia QuantisnowBiocardia Phase 3 CardiAMP-HF Trial of Novel Cardiac Cell Therapy for Ischemic Heart Failure Shows Increased Survival, Decreased Cardiac Events, and Improved Quality of Life at Two YearsByQuantisnow·Wall Street's wire, on your screen.BCDA· BioCardia Inc.Health Care
